Evofem Biosciences, Inc. (EVFM) Financials
EVFM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 7.4 million | 80.2 million |
| Dec. 31, 2025 | 20.3 million | 89.7 million |
| Sept. 30, 2025 | 13.8 million | 84.0 million |
| June 30, 2025 | 14.4 million | 84.0 million |
EVFM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 2.3 million | 15000 |
| Dec. 31, 2025 | 28000 | 42000 |
| Sept. 30, 2025 | 336000 | 23000 |
| June 30, 2025 | -2.9 million | 31000 |
EVFM Net Income
No data available :(
EVFM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 2.4 million | 27000 | 27000 |
| Dec. 31, 2025 | 578000 | - | 54000 |
| Sept. 30, 2025 | 840000 | - | 196000 |
| June 30, 2025 | 748000 | - | 213000 |
EVFM Shares Outstanding
EVFM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 2000 | 518000 | 4.5 million | 2.1 million |
| Dec. 31, 2025 | 3000 | -2.8 million | 3.2 million | 2.1 million |
| Sept. 30, 2025 | - | 470000 | 4.5 million | 2.4 million |
| June 30, 2025 | 2000 | 746000 | 4.5 million | 2.6 million |
EVFM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 899000 | 485000 |
| Dec. 31, 2025 | 9.6 million | 3.0 million |
| Sept. 30, 2025 | 5.0 million | 985000 |
| June 30, 2025 | 4.8 million | 755000 |
EVFM
Price: $0.01
52 week price:
Earnings Per Share: -0.05 USD
P/E Ratio: -0.18
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.6 million
Ebitda: -1.8 millionMarket Capitalization: 1.1 million